NCT03471403Recruiting
Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
Source: ClinicalTrials.gov · Last updated 27 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to collect prospective observational data regarding patients with diagnosed Familial Adenomatous Polyposis (FAP) undergoing cold snare polypectomy for duodenal adenomas
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 13 Mar 2018
- Start date
- 10 Oct 2017
- Primary completion date
- 10 Oct 2027
- Lead sponsor
- Western Sydney Local Health District
- NCT number
- NCT03471403
What you commit to
- Study type: Observational
- Planned participants: 100
- From 10 Oct 2017 to the primary completion date, 10 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Bleeding diathesis
Other
- Patient's with known strictures/stenosis
- Pregnancy
- Patients who did not consent to study
Who the study is looking for
- Patient's diagnosed with a confirmed diagnosis of FAP (genetic testing) and able to give informed consent to involvement in trial. For patients who do not speak English, an interpreter will be asked to translate the informed consent
- Patients already commenced on endoscopic surveillance for FAP.
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Westmead Endoscopy Unit Coordinator of this site? Confirm its status | Westmead | Australia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.